Paradigm BioCapital Advisors LP 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:31 pm Sale | 2025-06-30 | 13G | Janux Therapeutics, Inc. JANX | Paradigm BioCapital Advisors LP | 2,920,258 4.900% | -595,728 (-16.94%) | Filing |
| 2025-02-14 4:41 pm Purchase | 2024-12-31 | 13G | Janux Therapeutics, Inc. JANX | Paradigm BioCapital Advisors LP | 3,515,986 6.000% | 907,412 (+34.79%) | Filing |
| 2024-10-23 5:39 pm Purchase | 2024-10-16 | 13G | Janux Therapeutics, Inc. JANX | Paradigm BioCapital Advisors LP | 2,608,574 5.000% | 2,608,574 (New Position) | Filing |